Higher Hsp90β levels were found in NAFLD patients compared to non-NAFLD patients (median 6.46 ng/mL (0.38-30.73) versus 3.95 ng/mL (0.14-98.37), p = 0.046, Mann-Whitney U test, Figure 1). The gene discussed is HSP90AB1; the disease is metabolic dysfunction-associated steatotic liver disease.